Gleason Shane Thomas — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Gleason Shane Thomas has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $289K.

Profile

Gleason Shane Thomas

Shane Thomas Gleason is an executive at InspireMD, Inc., serving as Chief Commercial Officer. In the SEC filing dated January 16, 2026, he is listed as Chief Commercial Officer with total purchases of $0 and total sales of $0 in that filing. InspireMD focuses on the MicroNet stent platform and markets products such as the CGuard carotid Embolic Prevention System (EPS) and MGuard Prime EPS.

RoleChief Commercial Officer
Notability40/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-21NSPRInspireMD, Inc.S — Open-market sale22.8K$1.01$23K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale2.9K$1.59$5K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale7.2K$2.51$18K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale3.8K$2.51$9K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale1.6K$2.51$4K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale2.5K$2.51$6K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale10.0K$3.65$36K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale5.1K$2.46$13K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale7.1K$2.51$18K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale9.9K$2.55$25K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale2.5K$2.51$6K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale3.7K$2.46$9K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale2.5K$2.61$6K
2026-05-21NSPRInspireMD, Inc.S — Open-market sale3.9K$2.71$10K
2026-02-02NSPRInspireMD, Inc.S — Open-market sale2.0K$1.60$3K
2026-02-02NSPRInspireMD, Inc.S — Open-market sale2.9K$1.63$5K
2026-02-02NSPRInspireMD, Inc.S — Open-market sale5.0K$1.65$8K
2026-02-02NSPRInspireMD, Inc.S — Open-market sale12.4K$1.65$20K
2026-02-02NSPRInspireMD, Inc.S — Open-market sale4.8K$1.66$8K
2026-02-02NSPRInspireMD, Inc.S — Open-market sale8.4K$1.57$13K

Companies — Last 90 Days

Frequently Asked Questions

Who is Gleason Shane Thomas?

Shane Thomas Gleason is an executive at InspireMD, Inc., serving as Chief Commercial Officer. In the SEC filing dated January 16, 2026, he is listed as Chief Commercial Officer with total purchases of $0 and total sales of $0 in that filing. InspireMD focuses on the MicroNet stent platform and markets products such as the CGuard carotid Embolic Prevention System (EPS) and MGuar…

How many SEC Form 4 filings has Gleason Shane Thomas submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Gleason Shane Thomas been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 24 open-market sales ($289K) across all tracked filings.

Where can I see all of Gleason Shane Thomas's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Gleason Shane Thomas profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.